Pediatric Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis – 2021-2026

1
Presents a Research Report on
Pediatric Vaccines Market
The Pediatric Vaccines Market is segmented by
Product Type (Monovalent, Multivalent), by
Technology Type (Live Attenuated, Inactivated,
Subunit, Toxoid, Conjugate, and Others), by
Application Type (Infectious Diseases, Cancer,
and Allergy), and by Region (North America,
Europe, Asia-Pacific, and Rest of the World).


www.stratviewresearch.com
Market Reports
Advisory Consulting
Sourcing Intelligence
2
Pediatric Vaccines Market Growth and Forecast
Highlights Drivers

• Pediatric vaccines market is likely to witness a
  promising CAGR of 10.1 during the forecast
  period.
• The prime factor contributing to the demand for
  pediatric vaccines is the advancements in
  healthcare sector and rising prevalence of
  chronic diseases.
• Pediatric vaccines are biological preparations
  that are used to stimulate immunity against one
  or several diseases among children.
• These vaccines induce acquired immunity against
  ailments.
• The report provides detailed insights into the
  market dynamics to enable informed business
  decision making and growth strategy formulation
  based on the opportunities present in the market.

Pediatric Vaccines Market Snapshot Pediatric Vaccines Market Snapshot
Growth 10.1 for the next five years
Major Product Type Monovalent
Dominant Technology Type Conjugate
Key Application Type Infectious Diseases
Region with the highest demand North America
Key Players GlaxoSmithKline plc, Merck Sharp Dohme Corp., SANOFI, AstraZeneca, Pfizer, Inc., Zydus Cadila, Mitsubishi Tanabe Pharma Corporation, Panacea Biotec, Sinovac Biotech Ltd., Bio Med Pvt. Ltd
3
Market Insights

• By Product Type
• The market is segmented as monovalent and
  multivalent.
• The monovalent segment held the larger share by
  product type in 2019 and is expected to maintain
  its dominance owing to safety and stability
  associated with such vaccines coupled with the
  ability to develop a prompt immune response.
• By Technology Type
• The market is segmented as live attenuated,
  inactivated, subunit, toxoid, conjugate, and
  others.
• The conjugate segment held the largest share by
  technology type in 2019 and is expected to
  maintain its vanguard owing to the growing
  awareness regarding pneumococcal and
  meningococcal infections.
• By Application Type
• The market is segmented as infectious diseases,
  cancer and allergy.
• The infectious disease segment held the largest
  share by application type in 2019 and is expected
  to maintain its lead on account of the rising
  awareness regarding infectious diseases across
  the globe coupled with the improving government
  initiatives to prevent such diseases.

4
Market Insights

• By Region
• North America is estimated to contribute for the
  largest market share over the forecast period.
• he largest share can be attributed to the huge
  RD investments, presence of advanced healthcare
  infrastructure, presence of dominant market
  players, and high level of awareness regarding
  various medical conditions among general
  population.
• Asia-Pacific is expected to grow with the highest
  CAGR over the forecast period owing to the
  improving government initiatives to improve
  healthcare especially in emerging economies such
  as India and China.

5
Competitive Insights
Pediatric Vaccines Market, regional expansion,
and execution of mergers acquisitions are the
key strategies adopted by the major players to
gain a competitive edge in the market. Key
Companies Analysed

• GlaxoSmithKline plc
• Merck Sharp Dohme Corp.
• SANOFI
• AstraZeneca
• Pfizer, Inc.
• Zydus Cadila
• Mitsubishi Tanabe Pharma Corporation
• Panacea Biotec
• Sinovac Biotech Ltd.
• Bio Med Pvt. Ltd.

6
Research Methodology
Data Analysis Top Down and Bottom Up Approach)
Data Triangulation Data Evaluation and Multiple
Data Triangulation)
Final Deliverables Final Report with All Findings)
Stratview Research follows a rigorous methodology
with high emphasis on primary research and
multiple ways of data triangulation. We conduct
primary research across the value chain to
provide 360 degree view of the market.
Secondary Research
Stratview Research Internal Knowledgebase
Primary Research

• Annual Reports / Fact Book
• Company Websites
• Magazines / Publications
• Press Releases Journals
• Industry News
• Association Articles
• Government Documents
• Social Media
• Others

• Robust database across value chain
• In-house industry veterans as advisors
• Project based subject matter experts

• Industry Players
• Industry Experts
• Suppliers
• Customers
• Associations
• Government Institutions
• Others

7
Report Features

• This report provides market intelligence in the
  most comprehensive way. The report structure has
  been kept such that it offers maximum business
  value. It provides critical insights on the
  market dynamics and will enable strategic
  decision making for the existing market players
  as well as those willing to enter the market. The
  following are the key features of the report
• Market structure Overview, industry life cycle
  analysis, supply chain analysis.
• Market environment analysis Growth drivers and
  constraints, Porters five forces analysis, SWOT
  analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics Market share,
  product portfolio, product launches, etc.
• Attractive market segments and associated growth
  opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing
  and new players.
• Key success factors.

8
Market Segmentation

• The pediatric vaccines market is segmented into
  the following categories.
• Pediatric Vaccines Market Size, Share,
  Forecast, by Product Type
• Monovalent (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)
• Multivalent (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)
• Pediatric Vaccines Market Size, Share,
  Forecast, by Technology Type
• Live Attenuated (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Inactivated (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)
• Subunit (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)
• Toxoid (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• Conjugate (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• Pediatric Vaccines Market Size, Share,
  Forecast, by Application Type
• Infectious Diseases (Regional Analysis North
  America, Europe, Asia-Pacific, and RoW)
• Cancer (Regional Analysis North America, Europe,
  Asia-Pacific, and RoW)
• Allergy (Regional Analysis North America,
  Europe, Asia-Pacific, and RoW)

9
Market Segmentation

• Pediatric Vaccines Market Size, Share,
  Forecast, by Region
• North America (Country Analysis the USA, Canada,
  and Mexico)
• Europe (Country Analysis Germany, France, the
  UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis China, Japan,
  India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis Latin
  America, the Middle East, and Others)

10
About Stratview Research
Stratview Research is a global market
intelligence firm providing high quality
syndicated reports, custom research and
consulting services.
Our Services
Why Us?
High Customer Delight
Rich Industry Experience
Robust Methodology
Effective Business Decisions
11
Contact Us for More Information and Sample Pages
Ask for Sample Pages here https//www.stratviewr
esearch.com/Request-Sample/1197/pediatric-vaccines
-market.htmlform
12
Thank You